LifeVantage to Announce Third Quarter Fiscal Year 2017 Results on May 10, 2017

SALT LAKE CITY, April 26, 2017 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), announced today that it will release financial results for its third quarter ended March 31, 2017, after the stock market closes on Wednesday, May 10, 2017. The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time (4:30 p.m. Eastern Daylight Time) that same day.

Investors interested in participating in the live call can dial (888) 600-4863 from the U.S. International callers can dial (913) 312-0380. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 17, 2017, by dialing (844) 512-2921 from the U.S. and entering confirmation code 9166571, or (412) 317-6671 from international locations, and entering confirmation code 9166571.

There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), is a science-based direct selling company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim® Nrf2 and NRF1 Synergizers, its line of scientifically-validated dietary supplements, the TrueScience® Anti-Aging Skin Care Regimen, Petandim™ for dogs, the AXIO® energy product line and the PhysIQ™ Smart Weight Management System. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. www.lifevantage.com

Investor Relations Contacts:
                    
                    Cindy England 
                    Director of Investor Relations
                    (801) 432-9036
                    investor@lifevantage.com
                    
                    -or-
                    
                    Scott Van Winkle 
                    Managing Director, ICR 
                    (617) 956-6736
                    scott.vanwinkle@icrinc.com